Login    Join free Add to favorites    中文
home > news > Thermo Fisher Partners with the CDC to Accelerate Global Microbial Identification
Industry Updates | New Products | Supplier News | Upcoming Events | business | web
Thermo Fisher Partners with the CDC to Accelerate Global Microbial Identification

hits:890     Date:07/17/15

New software connects public health laboratories with MicrobeNet database to advance infectious disease surveillance

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher ScientificThrough a successful partnership with the Special Bacteriology Reference Laboratory at the Centers for Disease Control and Prevention (CDC), Thermo Fisher Scientific has developed an advanced software solution that enables global public health laboratories to directly access the CDC鈥檚 MicrobeNet online virtual reference lab database. Now, researchers can more quickly identify microbial pathogens potentially at the root of global outbreaks without needing to refer to multiple databases by instead utilizing one curated by subject matter experts in the field.

Thermo Fisher鈥檚 MicrobeBridge software platform is designed to seamlessly connect Sanger sequencing results to the MicrobeNet database. Currently, analyzing sequencing data is fragmented over multiple software packages. MicrobeBridge enables researchers to access more easily the public health information stored in MicrobeNet and informs laboratory-based surveillance and the general understanding of disease outbreaks.

鈥淒NA-based microbial identification has become an invaluable tool for public health scientists to identify and track infectious disease outbreaks,鈥 said Dan Didier, director of Public Health at Thermo Fisher Scientific. 鈥淵et data analysis has slowed the ability of public health laboratories to act swiftly. MicrobeBridge overcomes that hurdle and equips researchers with technology that helps them to respond more quickly to pathogens that threaten human health.鈥

MicrobeBridge integrates with all Applied Biosystems Capillary Electrophoresis instruments and automates the assembly and QC of raw Sanger sequencing data into a searchable format in the MicrobeNet database, thus minimizing the effort required to match and positively identify specimens. The company also plans to develop compatible software for Thermo Fisher鈥檚 next-generation sequencing and mass spectrometry platforms.

鈥淓xpanding MicrobeNet will allow public health laboratories anywhere in the world to run sequence-based, phenotypic or eventually other tests and match results against a highly curated database comprised of our unique collection of pathogens,鈥 said John R. McQuiston, Ph.D., Team Lead, Special Bacteriology Reference Laboratory, Bacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology at the CDC. 鈥淲ith the addition of MicrobeBridge, researchers and public health laboratories will now be able to easily acquire information on thousands of organisms curated by the pathogen subject matter experts at CDC.鈥

For more information about MicrobeBridge, please contact Dan Didier: dan.didier@thermofisher.com

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and approximately 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. Through our premier brands 鈥 Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services 鈥 we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit
www.thermofisher.com .

Contacts
Media Contact Information:
Thermo Fisher Scientific
Mauricio Minotta, +1 760-929-2456
Mauricio.Minotta@thermofisher.com
or
Chempetitive Group
Rachel Wallace, +1 978-969-2473
rwallace@chempetitive.com

Related News>> more
advertisement

Copyright(C) 2006-2017 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙